Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Caspofungin MeSH Descriptor Data 2026


MeSH Heading
Caspofungin
Tree Number(s)
D10.477.250
D12.644.365.250
D12.644.641.311.500
Unique ID
D000077336
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077336
Scope Note
A cyclic lipopeptide echinocandin and beta-(1,3)-D-glucan synthase inhibitor that is used to treat internal or systemic MYCOSES.
Entry Term(s)
Cancidas
Caspofungin Acetate
Caspofungin MSD
L 743,872
L 743872
L-743,872
L-743872
MK 0991
MK-0991
Pharm Action
Antifungal Agents
Enzyme Inhibitors
Registry Numbers
F0XDI6ZL63
0
VUW370O5QE
Related Numbers
VUW370O5QE
CAS Type 1 Name
Tetradecanamide, N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-((2-aminoethyl)amino)-20-((1R)-3-amino-1-hydroxypropyl)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)tetracosahydro-2,11,15-trihyd roxy-6-((1R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxo-1H-dipyrrolo(2,1-c:2',1'-l)(1,4,7,10,13,16)hexaazacycloheneicosin-9-yl)-10,12-dimethyl-
Public MeSH Note
2019; CASPOFUNGIN was indexed under ECHINOCANDINS and LIPOPEPTIDES 2008-2018; under PEPTIDES, CYCLIC 2005-2007; and under PEPTIDES 1997-2004
History Note
2019 (1997)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Caspofungin Preferred
L 743,872 Narrower
MK 0991 Narrower
Cancidas Narrower
Caspofungin Acetate Narrower
Caspofungin MSD Narrower
page delivered in 0.15s